[BJCORP] QoQ Annualized Quarter Result on 31-Jan-2011 [#3]

Stock
[BJCORP] BERJAYA CORPORATION BHD
Announcement Date
30-Mar-2011
Admission Sponsor
-
Sponsor
-
Financial Year
30-Apr-2011
Quarter
31-Jan-2011 [#3]
Profit Trend
QoQ- -23.12%
YoY- 479.15%
Quarter Report
Latest QR
Upcoming QR
BJCORP's Result
BJCORP's Financial Summary
View:
Show?
Annualized Quarter Result
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
Revenue 6,971,840 7,151,028 7,043,612 6,988,952 6,928,952 6,978,268 6,757,534 2.09%
PBT 1,115,934 1,561,588 861,551 816,860 849,060 951,132 595,600 51.80%
Tax -262,942 -189,280 -235,563 -221,376 -199,426 -201,572 -205,528 17.79%
NP 852,992 1,372,308 625,988 595,484 649,634 749,560 390,072 68.23%
-
NP to SH 587,088 1,082,340 352,168 325,958 424,008 501,852 79,990 276.30%
-
Tax Rate 23.56% 12.12% 27.34% 27.10% 23.49% 21.19% 34.51% -
Total Cost 6,118,848 5,778,720 6,417,624 6,393,468 6,279,318 6,228,708 6,367,462 -2.61%
-
Net Worth 6,297,415 6,362,025 6,101,475 6,093,794 6,070,308 6,229,150 5,693,546 6.93%
Dividend
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
Div - - 306,101 291,555 437,121 - 40,732 -
Div Payout % - - 86.92% 89.45% 103.09% - 50.92% -
Equity
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
Net Worth 6,297,415 6,362,025 6,101,475 6,093,794 6,070,308 6,229,150 5,693,546 6.93%
NOSH 4,374,724 4,371,324 4,372,876 4,373,327 4,371,216 4,356,353 4,073,219 4.86%
Ratio Analysis
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
NP Margin 12.23% 19.19% 8.89% 8.52% 9.38% 10.74% 5.77% -
ROE 9.32% 17.01% 5.77% 5.35% 6.98% 8.06% 1.40% -
Per Share
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
RPS 159.37 163.59 161.08 159.81 158.51 160.19 165.90 -2.63%
EPS 13.42 24.76 8.06 7.45 9.70 11.52 1.96 259.31%
DPS 0.00 0.00 7.00 6.67 10.00 0.00 1.00 -
NAPS 1.4395 1.4554 1.3953 1.3934 1.3887 1.4299 1.3978 1.97%
Adjusted Per Share Value based on latest NOSH - 4,387,162
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
RPS 119.21 122.27 120.43 119.50 118.47 119.32 115.54 2.10%
EPS 10.04 18.51 6.02 5.57 7.25 8.58 1.37 275.92%
DPS 0.00 0.00 5.23 4.99 7.47 0.00 0.70 -
NAPS 1.0768 1.0878 1.0432 1.0419 1.0379 1.0651 0.9735 6.93%
Price Multiplier on Financial Quarter End Date
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
Date 31/10/11 29/07/11 29/04/11 31/01/11 29/10/10 30/07/10 30/04/10 -
Price 1.04 1.19 1.14 1.09 1.08 1.08 1.71 -
P/RPS 0.65 0.73 0.71 0.68 0.68 0.67 1.03 -26.36%
P/EPS 7.75 4.81 14.16 14.62 11.13 9.38 87.08 -79.97%
EY 12.90 20.81 7.06 6.84 8.98 10.67 1.15 398.90%
DY 0.00 0.00 6.14 6.12 9.26 0.00 0.58 -
P/NAPS 0.72 0.82 0.82 0.78 0.78 0.76 1.22 -29.57%
Price Multiplier on Announcement Date
31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 30/04/10 CAGR
Date 29/12/11 29/09/11 29/06/11 30/03/11 30/12/10 29/09/10 30/06/10 -
Price 0.95 0.96 1.20 1.09 1.11 1.08 1.27 -
P/RPS 0.60 0.59 0.74 0.68 0.70 0.67 0.77 -15.28%
P/EPS 7.08 3.88 14.90 14.62 11.44 9.38 64.67 -77.02%
EY 14.13 25.79 6.71 6.84 8.74 10.67 1.55 334.63%
DY 0.00 0.00 5.83 6.12 9.01 0.00 0.79 -
P/NAPS 0.66 0.66 0.86 0.78 0.80 0.76 0.91 -19.22%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment